Basics |
Company: |
GeoVax Labs, Inc. |
IPO Date: |
September 25, 2020 |
Sector: |
Healthcare |
Industry: |
Biotech |
Market Cap: |
$15.76M |
Activated in VL: |
True |
Average Daily Range |
Avg Daily Range: |
$0.13 | 5.06%
|
Avg Daily Range (30 D): |
$0.07 | 3.28%
|
Avg Daily Range (90 D): |
$0.09 | 4.19%
|
Institutional Daily Volume |
Avg Daily Volume: |
.6M |
Avg Daily Volume (30 D): |
.49M |
Avg Daily Volume (90 D): |
1.17M |
Trade Size |
Avg Trade Size (Sh.): |
81 |
Avg Trade Size (Sh.) (30 D): |
246 |
Avg Trade Size (Sh.) (90 D): |
263 |
Institutional Trades |
Total Inst.Trades: |
13 |
Avg Inst. Trade: |
$.99M |
Avg Inst. Trade (30 D): |
$.57M |
Avg Inst. Trade (90 D): |
$.57M |
Avg Inst. Trade Volume: |
.04M |
Avg Inst. Trades (Per Day): |
1 |
Market Closing Trades |
Avg Closing Trade: |
$1.29M |
Avg Closing Trade (30 D): |
$1.29M |
Avg Closing Trade (90 D): |
$1.29M |
Avg Closing Volume: |
154.64K |
|
|
|
|
Financials |
|
TTM |
Q2 2024 |
Q1 2024 |
Basic EPS
|
$-.91
|
$-1.99
|
$-2.47
|
Diluted EPS
|
|
|
|
Revenue
|
$ 2.79M
|
$ .3M
|
$ M
|
Gross Profit
|
$
|
$
|
$
|
Net Income / Loss
|
$ -5.82M
|
$ -5.06M
|
$ -5.85M
|
Operating Income / Loss
|
$ -5.85M
|
$ -5.06M
|
$ -5.88M
|
Cost of Revenue
|
$
|
$
|
$
|
Net Cash Flow
|
$ 2.14M
|
$ 5.68M
|
$ -5.68M
|
PE Ratio
|
|
|
|
Splits |
Jan 31, 2024:
15:1
|
Sep 25, 2020:
20:1
|
Jan 24, 2020:
2000:1
|
May 02, 2019:
500:1
|
Apr 28, 2010:
50:1
|
|